Scientists are embarking on a large-scale clinical study of new personalised cancer therapies that could give clinicians a real-time view of how well treatments are working.
The £9m partnership between the Francis Crick Institute, five NHS trusts, charities and bioscience companies will spend four years examining the effectiveness of new immunotherapy treatments and exploring new ways to detect cancer.
